GW Pharmaceuticals Plc.

(NASDAQ:GWPH) (LSE:GWP)

Company Description:

GW Pharmaceuticals Plc (NASDAQ:GWPH) is developing a portfolio of cannabinoid medicines, including Sativex for the treatment of MS spasticity and cancer pain, and Epidiolex for the treatment of childhood epilepsy.

Latest News & Stories on GW Pharmaceuticals Plc. (NASDAQ:GWPH) (LSE:GWP)